ClinicalTrials.gov
ClinicalTrials.gov Menu

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00896493
Recruitment Status : Recruiting
First Posted : May 11, 2009
Last Update Posted : October 20, 2016
Sponsor:
Information provided by (Responsible Party):
Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2022
  Estimated Study Completion Date : December 2022